The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis
- PMID: 3204597
The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis
Abstract
We administered the Stanford Health Assessment Questionnaire functional disability questionnaire to a cohort of 400 patients with rheumatoid arthritis (RA) every 6 months during a mean followup of 3.1 years. Simple classification into 3 groups based on Functional Disability Index (FDI) scores (0-1, 1.1-2, 2.1-3) identified patients with increasingly more severe scores for clinical, psychological, and demographic variables; and FDI scores at entry predicted increased inpatient and outpatient utilization of services, and mortality. The FDI provided important and clinically useful current and predictive information regarding RA status, utilization of services, and mortality that was not available through conventional testing. Our data suggest that such information can be easily and inexpensively obtained.
Similar articles
-
The assessment and prediction of functional disability in rheumatoid arthritis.J Rheumatol. 1991 Sep;18(9):1298-306. J Rheumatol. 1991. PMID: 1757928
-
Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ Are Associated with and Predicted by Different Factors in Rheumatoid Arthritis.J Rheumatol. 2007 Sep;34(9):1837-40. Epub 2007 Aug 1. J Rheumatol. 2007. PMID: 17787050
-
Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.J Rheumatol. 2001 Nov;28(11):2416-24. J Rheumatol. 2001. PMID: 11708412
-
A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis.Rheum Dis Clin North Am. 2009 Nov;35(4):699-712, v. doi: 10.1016/j.rdc.2009.10.003. Rheum Dis Clin North Am. 2009. PMID: 19962614 Review.
-
Rheumatoid arthritis, disability and the workplace.Baillieres Best Pract Res Clin Rheumatol. 1999 Dec;13(4):675-88. doi: 10.1053/berh.1999.0053. Baillieres Best Pract Res Clin Rheumatol. 1999. PMID: 10652647 Review.
Cited by
-
Interleukin 6, interleukin 17, disease-related and contextual factor association with depression, and its severity in patients with rheumatoid arthritis.Clin Rheumatol. 2021 Mar;40(3):895-904. doi: 10.1007/s10067-020-05326-7. Epub 2020 Aug 13. Clin Rheumatol. 2021. PMID: 32789817
-
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.Drugs. 2005;65(4):473-96. doi: 10.2165/00003495-200565040-00004. Drugs. 2005. PMID: 15733011 Review.
-
Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis.Arch Rheumatol. 2017 Jan 18;32(1):53-59. doi: 10.5606/ArchRheumatol.2017.6078. eCollection 2017 Mar. Arch Rheumatol. 2017. PMID: 30375535 Free PMC article.
-
Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis.Arthritis Rheum. 2011 Nov;63(11):3216-25. doi: 10.1002/art.30542. Arthritis Rheum. 2011. PMID: 21965129 Free PMC article.
-
A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis.Rheumatol Int. 2013 Nov;33(11):2731-6. doi: 10.1007/s00296-013-2800-6. Epub 2013 Jun 21. Rheumatol Int. 2013. PMID: 23793389
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical